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Abstract
Atrophy of the olfactory epithelium (OE) associated with impaired olfaction and dry nose represents one of the most
common phenotypes of human aging. Impairment in regeneration of a functional olfactory epithelium can also occur in
response to injury due to infection or nasal surgery. These complications occur more frequently in aged patients. Although
age is the most unifying risk factor for atrophic changes and functional decline of the olfactory epithelium, little is known
about molecular mechanisms that could influence maintenance and repair of the olfactory epithelium. Here, we analyzed
the influence of telomere shortening (a basic mechanism of cellular aging) on homeostasis and regenerative reserve in
response to chemical induced injury of the OE in late generation telomere knockout mice (G3 mTerc
2/2) with short
telomeres compared to wild type mice (mTerc
+/+) with long telomeres. The study revealed no significant influence of
telomere shortening on homeostatic maintenance of the OE during mouse aging. In contrast, the regenerative response to
chemical induced injury of the OE was significantly impaired in G3 mTerc
2/2 mice compared to mTerc
+/+ mice. Seven days
after chemical induced damage, G3 mTerc
2/2 mice exhibited significantly enlarged areas of persisting atrophy compared to
mTerc
+/+ mice (p=0.031). Telomere dysfunction was associated with impairments in cell proliferation in the regenerating
epithelium. Deletion of the cell cycle inhibitor, Cdkn1a (p21) rescued defects in OE regeneration in telomere dysfunctional
mice. Together, these data indicate that telomere shortening impairs the regenerative capacity of the OE by impairing cell
cycle progression in a p21-dependent manner. These findings could be relevant for the impairment in OE function in elderly
people.
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Introduction
The olfactory epithelium (OE) represents a neuroepithelium
with low rates of cell turnover but it can regenerate throughout the
life span of vertebrates in response to injury or inflammatory
damage [1,2]. The OE consists of three major cell types: olfactory
receptor neurons, supporting cells and basal cells [3,4]. The basal
cell layer of the olfactory epithelium contains neuronal progenitor
cells generating new receptor neurons throughout life [5,6].
Dysfunction of the OE (hyposmia, dry nose) is a very frequent
clinical symptom in the elderly occurring in .75% of 80 year old
people [7]. Several clinical conditions can precipitate OE
dysfunction including nasal infections and surgery. Morphologi-
cally, OE dysfunction has been associated with reduced thickness
of the epithelium and impaired mucosa secretion [8] indicating
that regenerative dysfunction and atrophic changes of the OE
could contribute to the age associated development of hyposmia.
In addition, olfactory dysfunction associates with some neuronal
disease including Alzheimer’s Disease and Parkinson’s Disease
[9,10].
The association between aging and the evolution of OE
dysfunction indicates that molecular mechanisms of aging may
also impair the homeostasis and/or the regenerative capacity of
the OE. It has been postulated that hormonal changes may be
involved in the development of OE atrophy [11,12]. Molecular
alterations that contribute to the decline in OE homeostasis and
regeneration have yet to be delineated.
Telomere shortening represents one molecular mechanism,
which can limit cell proliferation and the regenerative capacity of
tissues. Telomeres form the end structures of human chromosomes
[13]. They consist of simple tandem DNA repeats and telomere
binding proteins [14]. The main function of telomeres is to cap
chromosomal ends to prevent chromosomal stability. Telomeres
shorten with each round of cell division due to the ‘end-replication
problem’ of DNA polymerase and due to processing of telomeres
during S-phase [15]. When telomeres reach a critically short
length they lose capping function and 3 to 4 dysfunctional
telomeres per cell are sufficient to induce the DNA damage
response leading to a permanent cell cycle arrest (replicative
senescence) or apoptosis [16].
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limits the proliferative capacity of primary human cells to a finite
number of cell divisions [17]. Telomere shortening has also been
shown to impair the proliferative capacity of neuronal stem cells
[18]. There is growing evidence that telomeres shorten in various
tissues during human aging [19]. Moreover, telomere shortening is
accelerated by chronic diseases that increase the rate of cell
turnover, e.g. chronic liver disease or chronic HIV infection
[20,21]. Telomerase can synthesize telomeres de novo [22].
However, in humans, the expression of the catalytic subunit of
telomerase (TERT) is postnatally suppressed in most somatic
tissues and this suppression limits telomere maintenance and the
proliferative capacity of most somatic cells [23]. During aging,
telomeres shorten also in human stem cells indicating that low
levels of telomerase are not sufficient to maintain stable telomeres
in stem cells during aging [24]. Recent studies have provided
evidence that telomerase mutations are the cause of some rare
diseases in humans leading to accelerated telomere shortening,
organ failure (bone marrow failure, lung fibrosis), and premature
death of the patients [25,26]. Together, these data indicate that
human telomeres are limited and can represent the cause of
impaired organ maintenance during human aging and disease.
Studies on telomerase knockout mice (lacking the RNA
component of telomerase: TERC) have revealed first experimental
evidence that telomere shortening limits organ homeostasis and
regeneration by induction of cell cycle arrest or apoptosis [27–29].
The possible contribution of telomere shortening to maintenance
and regeneration of the OE has not been investigated.
Here we analyzed the consequences of telomere shortening in
G3 mTerc
2/2 mice compared to mTerc
+/+ mice with long telomeres
on maintenance and regeneration of the OE in response to
chemical induced tissue damage. The study shows that telomere
shortening leads to regional defects in OE regeneration in response
to damage coupled with impaired cell proliferation in the affected
areas.
Results
Telomere shortening does not impair homeostasis of the
olfactory epithelium in aging mice
To evaluate influences of telomere shortening on the develop-
ment and postnatal maintenance of the olfactory epithelium (OE)
cross section were prepared from the basal nose of 2–3 month old
mTerc
+/+ and G3 mTerc
2/2 mice (n=10 per group) and 10–12
month old mTerc
+/+ and G3 mTerc
2/2 mice (n=10 per group). In
agreement with previous studies on other organ compartments,
quantitative fluorescence in situ hybridisation revealed significantly
shorter telomeres in the OE of 6–8 month old G3 mTerc
2/2
compared to mTerc
+/+ mice (Fig. 1A, B). Histological analysis of
the OE revealed a normal appearance of the OE in 2–3 month old
G3 mTerc
2/2 mice compared to age matched mTerc
+/+ mice
(Figure 2A,B) indicating that telomere shortening did not impair
Figure 1. Shortened telomeres in the olfactory epithelium of G3 mTerc
2/2 mice. (A, B): Distribution of the mean telomere fluorescence
intensity (TFI) of cells of the olfactory epithelium in 6–8 month old mTerc
+/+ mice (A) and of G3 mTerc
2/2 mice (B) (n=4 mice per group). The dotted
line shows the mean TFI of olfactory epithelial cells in mice of the two cohorts. Note that the olfactory epithelium of G3 mTerc
2/2 have shorter
telomeres than mTerc
+/+ mice (P=0.0207).
doi:10.1371/journal.pone.0027801.g001
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sections from the basal nose of 10–12 month old mice did not
reveal a significant influence of telomere shortening on the
morphology of the OE during aging (Figure 2C, D). Moreover,
immunostaining for specific differentiation markers (olfactory
marker protein (OMP) for olfactory receptor neurons; growth-
associated protein 43 (GAP43) for immature olfactory receptor
neurons) and proliferation markers (proliferating cell nuclear
antigen = PCNA) did not reveal a significant influence of
telomere shortening on the normal differentiation and cell
composition of the OE (Figure 2E-K). Together, these data
indicated that telomere shortening did not impair development
and postnatal maintenance of a normally differentiated OE in
young and aged mice.
Telomere shortening impairs regeneration of the
olfactory epithelium in response to chemical induced
damage in adult mice
To investigate the influence of telomere shortening on the
regenerative response of the OE, 6 month old G3 mTerc
2/2 and
mTerc
+/+ mice were treated with intranasal Triton-X (0.7%)
application (n=5 mice per group). To determine possible
influences of telomere shortening on chemical induced tissue
damage, cross section analysis of the OE was carried out in a
cohort of mice at day 2 after Triton-X application. This analysis
did not reveal significant differences between the two cohorts, both
showing strong damage to 80–90% of the OE (Figure 3A-D).
These data indicated that telomere shortening had no significant
influence on the severity of acute OE damage in response to
Triton-X application.
Regeneration of the OE in response to chemical injury in mice
is known to involve a strong induction of cell cycle activity leading
to a near complete restoration of the OE after 7 days of injury
[30]. To determine whether telomere shortening had an influence
on the regenerative response after Triton-X treatment, cross
sections of the OE were analyzed 7 days after Triton-X induced
OE damage. In agreement with previous publications, mTerc
+/+
mice showed a near complete restoration of a 5–6 cell layer thick
OE in large areas of the OE at this time point (Figure 4A).
Regeneration of the OE was delayed in age-matched G3 mTerc
2/2
mice (Figure 4B-E). Specifically the OE of G3 mTerc
2/2 mice
exhibited significantly increased areas of the OE that did not
regenerate at all (0–2 cell layers, Figure 4E) or showed only
incomplete regeneration (3–4 cell layer thickness, Figure 4G).
These results provided the first evidence that telomere shortening
impaired regenerative responses of the OE in response to chemical
induced injury.
Figure 2. Telomere shortening does not affect homeostasis of the olfactory epithelium in aging mice. (A, B): Representative
photographs of hematoxylin and eosin-stained longitudinal sections of the OE from 2–3 month old (A) mTerc
+/+ and (B) G3 mTerc
2/2 mice, and 10–12
month old (C) mTerc
+/+ and (D) G3 mTerc
2/2 mice. (E-J) Immunohistological analysis of longitudinal sections of the OE 10–12 month old (E, G, I)
mTerc
+/+ and (F, H, J) G3 mTerc
2/2 mice: (E, F) Olfactory marker protein (OMP), (G, H) GAP43 and (I, J) proliferating cell nuclear antigen (PCNA). White
arrows point to PCNA positive cells (G, H). (K) Histogram showing percentage of PCNA-positive cells in the OE of 10–12 month old mTerc
+/+ and G3
mTerc
2/2 mice (n=10 mice per group, P=0.4580).
doi:10.1371/journal.pone.0027801.g002
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cells in the regenerating olfactory epithelium of adult
mice in a p21-dependent manner
To analyse possible mechanisms of impaired regeneration of the
OE in G3 mTerc
2/2 mice with short telomeres compared to mTerc
+/
+ mice with a long telomere reserve, TUNEL (terminal deoxynu-
cleotidyl transferase-mediated dUTP-biotin nick end labelling)
staining was carried out to determine the number of apoptotic
cells. In addition, mice were pulse labelled with bromodesoxyur-
idine (BrdU) to mark regenerating cells in S-phase of the cell cycle.
Quantification of TUNEL-positive cells at day 7 after Triton-X
application did not reveal significant differences in the rate of
apoptosis, which was low in both cohorts (,10%, data not shown).
Also the areas of impaired regeneration in the OE of G3 mTerc
2/2
mice did not exhibit an increase in apoptotic cells (data not shown).
In contrast, BrdU staining of regenerating cells revealed a strong
reductioninBrdU-positivecellsinregeneratingOEofG3mTerc
2/2
mice compared to mTerc
+/+ mice, especially in areas of 2–4 and 4–6
cell thickness, at day 7 after chemical induced injury (Figure 5A-C).
Together, these data indicated that telomere shortening led to
impairments in OE regeneration by inhibiting the proliferative
response in the regenerating areas. Staining for cell cycle inhibitors
(p21) that are known to induce cell cycle arrest in response to
telomere dysfunction [29,31,32]. Immunohistochemical staining at
day 7 after Triton-X application did not reveal an increased
expression of p21 in the OE of G3 mTerc
2/2 mice compared to
mTerc
+/+ mice (data not shown). Similarly, quantitative PCR
analysis on whole tissue lysates of the OE containing region did
not show an upregulation of p21 mRNA in G3 mTerc
2/2 mice
compared to mTerc
+/+ mice (data not shown). However, both
techniques have limitation since preparation of the OE for IHC
staining requires a 2-weeks decalcification protocol, which may
damage protein epitopes. In addition, whole tissue lysates from the
OE region only contains a small percentage of regenerative cells
from the OE. Therefore, a genetic experiment was carried out to
evaluate the functional influence of p21 gene status (also known as
Cdkn1a) on OE regeneration in response to chemical induced
damage in 6–8 month old G3 mTerc
2/2, p21
+/+ and G3 mTerc
2/2,
p21
2/2 mice. These experiments revealed that deletion of p21
rescued the regenerative response of the OE of G3 mTerc
2/2 mice
in response to chemical induced damage (Figure 5D).
Discussion
The current study provides the first experimental evidence that
telomere shortening impairs the regeneration of the olfactory
epithelium in response to chemical induced injury in mice. OE
proliferation was impaired in regenerating areas of the injured OE
of telomere dysfunctional mice (G3 mTerc
2/2) compared to
Figure 3. Morphological Analysis of the olfactory epithelium at day 2 after Triton-X application. (A,B) Representative photographs of
hematoxylin and eosin-stained sagittal sections of the OE, two days after intranasal injection of Triton-X in 6 month old (A) G3 mTerc
2/2 and (B)
mTerc
+/+ mice. There are no significant differences between the two cohorts, both showing strong damage to 80–90% of the OE. The histograms
show the percentage of the chemically damaged olfactory epithelium in mTerc
+/+ and G3 mTerc
2/2 mice at two days after Triton-X induced injury: (C)
percentage of damaged epithelium of 0–4 cell layer thickness (P=0.7887), (D) percentage of completely damaged epithelium of 0–2 cell layer
thickness (P=0.8208).
doi:10.1371/journal.pone.0027801.g003
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+/+ mice. Upregulation of the cell cycle inhibitor p21 is
associated with senescence of human fibroblast in culture and also
with impaired proliferation of the intestinal epithelium of G3
mTerc
2/2 mice (Choudhury et al. 2007, Brown et al. 1997). In this
study we could not detect an upregulation of p21 in the OE of G3
mTerc
2/2 mice compared to mTerc
+/+ mice, which could be due to
technical limitation (see above). However, our functional studies
on G3 mTerc
2/2, p21
2/2 double knockout mice revealed that p21
deletion rescued impairments in OE regeneration in response to
chemical induced OE damage in telomere dysfunctional mice.
Together, these experiments indicate that telomere dysfunction
impairs regeneration of the OE in a p21 dependent manner.
Previous studies have provided experimental evidence that the
cellular turnover of the OE is low in wild-type mice and turnover
rates decrease with aging [33]. The current study did not reveal a
negative impact of telomere shortening on the maintenance of the
OE under homeostatic conditions in aging G3 mTerc
2/2 mice. A
possible explanation indicates that impairments in cell proliferation
canbe compensated inorgan systemswith lowrates ofcell turnover.
In agreement with this assumption, telomere dysfunction induced
atrophy of tissues in G3 mTerc
2/2 mice predominantly affects organ
systems with high rates of cell turnover [28,34]. The data on
impaired regeneration of the OE in chemically injured G3 mTerc
2/2
mice indicate that compensatory regeneration may exhaust in the
context of increased rates of proliferation that are required to
regenerate the tissue in response to injury. However, we also
recognized that the regeneration of the OE of G3 mTerc
2/2 mice
could be completed at later time points after chemical injury (3
weeks, data not shown) indicating that an acute, single injury can be
restored despite impairments in regeneration. However, this healing
occurs only with a significant delay. It remains to be investigated
whether telomere shortening and p21 upregulation may contribute
to the evolution of OE dysfunction in elderly humans. According to
the current study this mechanisms could especially contribute to the
evolution OE atrophy in response to acute or chronic damage, such
as in response to surgery or infections.
Materials and Methods
Animals
mTerc
2/2 [27], p21
2/2 [35] and as control mTerc
+/+ mice on
C57BL/6J background were used in this study. mTerc
+/2 mice
Figure 4. Telomere shortening impairs regeneration of the olfactory epithelium in response to injury. (A, B) Representative
photographs of hematoxylin and eosin-stained sagital sections of the nasal cavity, seven days after intranasal injection of Triton-X in 6 month old (A)
G3 mTerc
2/2 and (B-E) mTerc
+/+ mice. Dotted line in A and B marks incompletely regenerated epithelium of 0–2 cell layer thickness, double line marks
incompletely regenerated epithelium of 3–4 cell layer thickness, dot/bar line marks completely regenerated epithelium of 5–6 cell layer thickness.
Representative high-power photographs of G3 mTerc
2/2 mice showing (C) incompletely regenerated epithelium with 0–2 cell layer thickness (dotted
line), (D) 3–4 cell layer thickness (double linier) (E) completely regenerated olfactory epithelium (E). (F, G) The histograms show the percentage of the
olfactory epithelium with incomplete regeneration in mTerc
+/+ and G3 mTerc
2/2 mice at seven days after Triton-X induced injury: (F) percentage of
incompletely regenerated epithelium of 0–2 cell layer thickness, (G) percentage of incompletely regenerated epithelium of 0–4 cell layer thickness.
doi:10.1371/journal.pone.0027801.g004
Telomere Shortening Impairs Regeneration of the OE
PLoS ONE | www.plosone.org 5 November 2011 | Volume 6 | Issue 11 | e27801were crossed with p21
2/2 mice. Heterozygous offsprings were
crossed with each other to generate G1 mTerc
2/2 p21
2/2 mice.
Those mice where crossed until the third generation of the
Telomerase knockout G3 mTerc
2/2 p21
2/2. Mice were kept in a
pathogen free environment where fed with ad libidum access to
food and water. The animal experiments were approved by the
government of the state of Baden-Wu ¨rttemberg (animal protocol
number 35/915.81–3–919).
Lesions
Mice from G3 mTerc
2/2 mice and mTerc
+/+ mice were treated
with a single intranasal irrigation with 0.7% of Triton-X in 0.15%
NaCl. Control mice were treated with same volume of 0.9%
saline.
In vivo BrdU incorporation assay
In vivo labelling of proliferating cells was performed by BrdU
labelling [i.p. injection of BrdU 30 mg/kg body weight]. G3
mTerc
2/2 mice and mTerc
+/+ mice were injected with a
bromodeoxyuridine (5-bromo-2-deoxyuridine; BrdU) solution
every day and 7 days later they were killed and the head without
skin were collected and fixed with 4% paraformaldehyde
overnight.
Decalcification
The facial bones were decalcifyed with 15% EDTA 0.5% PFA
in PBS (pH 8.0). Decalcification is carried out at 4uC with gentle
agitation. The fluid is renewed every 1–2 days until the calcium
salts were completely removed.
Telomere length measurement by quantitative
fluorescence in situ hybridization
Paraffin slides were unmasked and than incubated in Pepsine
solution for 10 min at 37uC (100 mg Pepsine; 84 ml HCl 37% up
to 100 ml H2O) and washed in PBS. The hybridisation mix
(10 mM Tris pH 7,2; MgCl2 buffer : 7,02 mM Na2HPO3,
2,14 mM MgCl2, 0,77 mM citric acid; 70% deionized formamide;
0,5 mg/ml PNA probe 5 `-Cy3-CCC TAA CCC TAA CCC TAA-
39 Panagene; 0,25% Roche blocking reagent) was added to the
sections and denatured at 80uC for 3 min followed by 2 h
incubation in the dark. Slides were incubated in 70% formamide,
10 mM Tris (pH 7,2), 0,1% BSA two times for 20 min and
Figure 5. Limited proliferation potential of the OE in telomere deficient mice. (A,B) Representative photographs of BrdU-stained
longitudinal sections of the olfactory epithelium, 7 days after Triton-X treatment in (A) mTerc
+/+ and (B) G3 mTerc
2/2 mice. (C) Histogram showing
BrdU positive cells in the OE of G3 mTerc
+/+ and mTerc
+/+ mice. Note that there is no significant difference of the ratio of BrdU positive cells v.s.
negative cells between mTerc
+/+ and G3 mTerc
2/2 mice in injured olfactory epithelium of one cell layer thickness (P=0.216) but there was a
significant reduction of BrdU positive cells in G3 mTerc
2/2 compared to mTerc
+/+ mice in injured olfactory epithelium of three cell layer thickness
(P=0.008) and 5–6 cell layer thickness (P=0.0293), n=5 mice per group. (D) The histogram shows the percentage of the olfactory epithelium with
incomplete regeneration (0–2 cell layer thickness) in 6–8 month mice of the indicated genotypes at 7 days after Triton-X induced injury. Note that p21
deletion rescues regenerative defects in G3 mTerc
2/2 mice. The cohorts in this experiment show an overall higher rate of tissue damage compared to
the previous experiment depicted in Figures 3 and 4.
doi:10.1371/journal.pone.0027801.g005
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was measured by the TFL analysis software program [36].
Histology and Immunohistochemical stainings
Immunofluorescence was performed on 5 mm thick paraffin
sections. Sections were deparaffinized and rehydrated in series of
ethanol and unmasked in 1 mM sodium citrate buffer by heating
at boiling temperature for 5 min and then heating at sub-boiling
temperature for 10 min and then allowed to cool down at RT for
40 min. The slides were then washed in PBS twice and incubated
with primary antibody for OMP (Biosensis, 1:300 dilution), GAP
43 (Biocompare, 1: 300 dilution), BrdU (BectonDickinson 1:100
dilution) and PCNA (Calbiochem, 1:50 dilution) either over night
at 4uC or for 2 h in humid chamber at room temperature. The
slides were washed twice with PBS before treated with secondary
antibody, anti-mouse IgG Cy3-conjugated (Cat No. C2181
Sigma-Aldrich, 1:300 dilution). Bound antibodies were visualized
using 1 mg/ml 3,39 diaminobenzidine tetrahydrochloride (Sigma
Chemical) for BrdU staining. Sections were dehydrated through a
series of graded alcohols and Microclearing and mounted with
Vitro-Clud (Microm Microtech).
The evaluation was made as the percent of positive cells and was
counted in 10 low power fields (200 x) per mouse.
Author Contributions
Conceived and designed the experiments: MWR MOS GR KLR.
Performed the experiments: MWR YBN AL HR DRT. Analyzed the
data: MWR YBN DRT. Contributed reagents/materials/analysis tools:
YBN HR. Wrote the paper: MWR YBN AL KLR.
References
1. Graziadei PP, Graziadei GA (1979) Neurogenesis and neuron regeneration in
the olfactory system of mammals. I. Morphological aspects of differentiation and
structural organization of the olfactory sensory neurons. J Neurocytol 8: 1–18.
2. Graziadei PP, Levine RR, Graziadei GA (1978) Regeneration of olfactory axons
and synapse formation in the forebrain after bulbectomy in neonatal mice. Proc
Natl Acad Sci U S A 75: 5230–5234.
3. De Lorenzo AJ (1957) Electron microscopic observations of the olfactory mucosa
and olfactory nerve. J Biophys Biochem Cytol 3: 839–850.
4. Matulionis DH (1975) Ultrastructural study of mouse olfactory epithelium
following destruction by ZnSO4 and its subsequent regeneration. Am J Anat
142: 67–89.
5. Graziadei GA, Graziadei PP (1979) Neurogenesis and neuron regeneration in
the olfactory system of mammals. II. Degeneration and reconstitution of the
olfactory sensory neurons after axotomy. J Neurocytol 8: 197–213.
6. Schwartz Levey M, Chikaraishi DM, Kauer JS (1991) Characterization of
potential precursor populations in the mouse olfactory epithelium using
immunocytochemistry and autoradiography. J Neurosci 11: 3556–3564.
7. Doty RL (1979) A review of olfactory dysfunctions in man. Am J Otolaryngol 1:
57–79.
8. Welge-Lu ¨ssen A (2009) Ageing, neurodegeneration, and olfactory and gustatory
loss. B-ENT 5(Suppl 13): 129–132.
9. Doty RL (1991) Olfactory capacities in aging and Alzheimer’s disease.
Psychophysical and anatomic considerations 640: 20–27.
10. Wysocki CJ, Pelchat ML (1992) The effects of aging on the human sense of smell
and its relationship to food choice. Crit. Rev. Food Sci. Nutr 33: 63–82.
11. Sundermann EE, Gilbert PE, Murphy C (2008) The effect of hormone therapy
on olfactory sensitivity is dependent on apolipoprotein E genotype. Hormones
and Behavior 54: 528–533.
12. Jenkin A, Renner D, Hahn F, Larsen J (2000) A case of primary amenorrhea,
diabetes and anosmia. Gynecol Endocrinol 14: 65–70.
13. Blackburn EH (1991) Structure and function of telomeres. Nature 350: 569–573.
14. de Lange T, Shiue L, Myers RM, Cox DR, Naylor SL, et al. (1990) Structure
and variability of human chromosome ends. Mol Cell Biol 10: 518–527.
15. Morin GB (1989) The human telomere terminal transferase enzyme is a
ribonucleoprotein that synthesizes TTAGGG repeats. Cell 59: 521–529.
16. Shay JW, Wright WE (2004) Telomeres in dyskeratosis congenita. Nat Genet 36:
437–438.
17. Allsopp RC, Vaziri H, Patterson C, Goldstein S, Younglai EV, et al. (1992)
Telomere length predicts replicative capacity of human fibroblasts. Proc Natl
Acad Sci U S A 89: 10114–10118.
18. Ferro ´n SR, Marque ´s-Torrejo ´n MA, Mira H, Flores I, Taylor K, et al. (2009)
Telomere shortening in neural stem cells disrupts neuronal differentiation and
neuritogenesis. J Neurosci 29: 14394–14407.
19. Frenck RW, Jr., Blackburn EH, Shannon KM (1998) The rate of telomere
sequence loss in human leukocytes varies with age. Proc Natl Acad Sci U S A 95:
5607–5610.
20. Takubo K, Nakamura K, Izumiyama N, Furugori E, Sawabe M, et al. (2000)
Telomere shortening with aging in human liver. J Gerontol A Biol Sci Med Sci.
55: B533–536.
21. Feng YR, Biggar RJ, Gee D, Norwood D, Zeichner SL, et al. (1999) Long-term
telomere dynamics: modest increase of cell turnover in HIV-infected individuals
followed for up to 14 years. Pathobiology 67: 34–38.
22. Greider CW, Blackburn EH (1987) The telomere terminal transferase of
Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity.
Cell 51: 887–898.
23. Meyerson M, Counter CM, Eaton EN, Ellisen LW, Steiner P, et al. (1997)
hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in
tumor cells and during immortalization. Cell 90: 785–795.
24. Vaziri H, Benchimol S (1999) Alternative pathways for the extension of cellular
life span: inactivation of p53/pRb and expression of telomerase. Oncogene 18:
7676–7680.
25. Vulliamy T, Marrone A, Goldman F, Dearlove A, Bessler M, et al. (2001)
Mason PJ, Dokal I. The RNA component of telomerase is mutated in autosomal
dominant dyskeratosis congenita. Nature 413: 432–435.
26. Armanios MY, Chen JJ, Cogan JD, Alder JK, Ingersoll RG, et al. (2007)
Telomerase mutations in families with idiopathic pulmonary fibrosis.
N Engl J Med. 356: 1317–1326.
27. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, et al. (1997)
Telomere shortening and tumor formation by mouse cells lacking telomerase
RNA. Cell 91: 25–34.
28. Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, et al. (1999) Longevity,
stress response, and cancer in aging telomerase-deficient mice. Cell 96: 701–712.
29. Choudhury AR, Ju Z, Djojosubroto MW, Schienke A, Lechel A, et al. (2007)
Cdkn1a deletion improves stem cell function and lifespan of mice with
dysfunctional telomeres without accelerating cancer formation. Nat Genet 39:
99–105.
30. Min YG, Kim JW, Hong SC, Dhong HJ, Jarin PR, et al. (2003) Pathogenetic
mechanism of olfactory cell injury after exposure to sulfur dioxide in mice.
Laryngoscope 113: 2157–2162.
31. Brown JP, Wei W, Sedivy JM (1997) Bypass of senescence after disruption of
p21CIP1/WAF1 gene in normal diploid human fibroblasts. Science 277:
831–834.
32. Begus-Nahrmann Y, Lechel A, Obenauf AC, Nalapareddy K, Peit E, et al.
(2009) p53 deletion impairs clearance of chromosomal-instable stem cells in
aging telomere-dysfunctional mice. Nat Genet 41: 1138–1143.
33. Kondo K, Suzukawa K, Sakamoto T, Watanabe K, Kanaya K, et al. (2010)
Age-related changes in cell dynamics of the postnatal mouse olfactory
neuroepithelium: cell proliferation, neuronal differentiation, and cell death.
J Comp Neurol 518: 1962–1975.
34. Lee HW, Blasco MA, Gottlieb GJ, Horner JW, 2nd, Greider CW, et al. (1998)
Essential role of mouse telomerase in highly proliferative organs. Nature 392:
569–574.
35. Deng C, Zhang P, Harper JW, Elledge SJ, Leder P (1995) Mice lacking
p21CIP1/WAF1 undergo normal development, but are defective in G1
checkpoint control. Cell 82: 675–684.
36. Poon SS, Martens UM, Ward RK, Lansdorp PM (1999) Telomere length
measurements using digital fluorescence microscopy. Cytometry 36: 267–278.
Telomere Shortening Impairs Regeneration of the OE
PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e27801